OTC healthcare products firm Perrigo Company has appointed the FDA’s Keith Webber to be its head of Regulatory Review. The …
ProBioGen secures extended GMP authorisation for viral manufacturing facility
PlaqueTec coronary disease trial reaches 100 patients across eight NHS centres
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework